Tocilizumab (Actemra) for Giant Cell Arteritis

被引：0
|
作者：
不详
机构：
来源：
MEDICAL LETTER ON DRUGS AND THERAPEUTICS | 2017年 / 59卷 / 1530期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：161 / 162
页数：2
相关论文
共 50 条
  • [1] The Cost-Effectiveness of Tocilizumab (Actemra) Therapy in Giant Cell Arteritis
    Jogimahanti, Arjun V.
    Kini, Ashwini T.
    Irwin, Lauren E.
    Lee, Andrew G.
    [J]. JOURNAL OF NEURO-OPHTHALMOLOGY, 2021, 41 (03) : 342 - 350
  • [2] Tocilizumab in giant cell arteritis
    Thorley, Jennifer
    [J]. LANCET RHEUMATOLOGY, 2021, 3 (02): : E100 - E100
  • [3] Tocilizumab in Giant Cell Arteritis
    Mariano, Vincent J.
    Frishman, William H.
    [J]. CARDIOLOGY IN REVIEW, 2018, 26 (06) : 321 - 330
  • [4] Tocilizumab for giant cell arteritis
    Antonio, Aileen A.
    Santos, Ronel N.
    Abariga, Samuel A.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2022, (05):
  • [5] Tocilizumab in Giant Cell Arteritis
    Pflugfelder, J.
    [J]. ZEITSCHRIFT FUR RHEUMATOLOGIE, 2017, 76 (01): : 87 - 88
  • [6] Tocilizumab for giant cell arteritis
    Antonio, Aileen A.
    Santos, Ronel N.
    Abariga, Samuel A.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021, (08):
  • [7] Tocilizumab for the treatment of giant cell arteritis
    Schirmer, Michael
    Muratore, Francesco
    Salvarani, Carlo
    [J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2018, 14 (05) : 339 - 349
  • [8] Tocilizumab in the treatment of giant cell arteritis
    Leuchten, Nicolai
    Aringer, Martin
    [J]. IMMUNOTHERAPY, 2018, 10 (06) : 465 - 472
  • [9] Tocilizumab for giant cell arteritis: what is optimal?
    Kaymakci, M.
    Warrington, K. J.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2023, 41 (04) : 777 - 779
  • [10] Efficacy of tocilizumab in refractory giant cell arteritis
    Vinit, Julien
    Bielefeld, Philip
    Muller, Geraldine
    Besancenot, Jean-Francois
    [J]. JOINT BONE SPINE, 2012, 79 (03) : 317 - 318
12345